Skip to main content

What the FDA labels say about taking them together

Fluconazole and pacritinib

Pacritinib's FDA label of July 30, 2026 names fluconazole in its drug interactions section; the fluconazole labels PlainMeds reads (2) do not name pacritinib. The pacritinib label: “Monitor patients concomitantly receiving moderate CYP3A4 inhibitors (e.g., fluconazole) for increased adverse reactions and consider VONJO dose modifications based on safety.”

Check it at the source: the fluconazole FDA label on DailyMed (effective April 7, 2026, Zydus Pharmaceuticals (USA) Inc.); the pacritinib FDA label on DailyMed (effective July 30, 2026, Sobi, Inc.).

What does the fluconazole label say about pacritinib?

Fluconazole's label (effective April 7, 2026) and its 1 other brand-application label do not name pacritinib in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (fluconazole), Zydus Pharmaceuticals (USA) Inc., effective April 7, 2026 (SPL set d1364455-1537-46d4-b093-38cca3be778f), via openFDA; the full label on DailyMed

What does the pacritinib label say about fluconazole?

Pacritinib label, drug interactions

Monitor patients concomitantly receiving moderate CYP3A4 inhibitors (e.g., fluconazole) for increased adverse reactions and consider VONJO dose modifications based on safety [see Dosage and Administration ( 2.5 )].

Source: FDA drug label (Vonjo), Sobi, Inc., effective July 30, 2026 (SPL set 4b5ab444-0e1a-4984-99db-76ad11a298ee), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

41Fluconazole generic labelers
0Pacritinib generic labelers
FluconazolePacritinib
Labeled forFungal infections, Urinary tract infectionsn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.380 per tablet 200 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?